Prostate / Prostate Cancer News From Medical News Today Latest Health News and Medical News posted throughout the day, every day.
Reovirus May Be A Novel Approach To Prostate Cancer Treatment
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research...
Millennium Announces First Clinical Data For TAK-700 Prostate Molecule At ASCO GU
Millennium: The Takeda Oncology Company today announced the presentation of safety, pharmacokinetic and efficacy data from the Phase I portion of a Phase I/II clinical trial evaluating TAK-700 in patients with metastatic castration resistant prostate cancer (mCRPC)...
Dietary Supplements Discouraged For Prostate Cancer Patients
Prostate-specific dietary supplements should not be taken during radiation therapy treatments because they have been shown to increase the radiosensitivity of normal prostate cell lines, leading to normal tissue complications, according to a study in the March issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society ...
PROGENSA(R) PCA3 Assay Can Help Guide Repeat Prostate Biopsy Decisions, Data Presented At Leading Medical Meeting Confirm
Gen-Probe's (Nasdaq: GPRO) PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco...
Prostate Cancer Therapy Correlates To Specialist Seen
New research published in today's issue of the Archives of Internal Medicine (Vol. 170, No. 5), by an investigator at The Cancer Institute of New Jersey (CINJ) and colleagues at Memorial Sloan-Kettering Cancer Center in New York, shows that the type of specialist that men with localized prostate cancer see can influence the form of therapy they ultimately receive...
Poniard Pharmaceuticals Presents Positive Survival Data From A Phase 2 Clinical Study Of Picoplatin In Metastatic Prostate Cancer
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC)...
UAB Cancer Center, Urologists Affirm Men Should Take Lead In Deciding Prostate Screening
Men who undergo prostate-cancer screening should discuss with a doctor the uncertainties, risks and benefits of the test before it is performed, says Edward Partridge, M.D., president-elect of the American Cancer Society (ACS) National Board of Directors and director of the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center...
AUA Responds To American Cancer Society Guideline For The Early Detection Of Prostate Cancer
American Cancer Society issued its new Guideline for the Early Detection of Prostate Cancer. The American Urological Association (AUA), which represents more than 16,000 urologists and urologic health professionals worldwide, issued the following statement in response to the new ACS document. The statement is attributable to AUA President Anton J. Bueschen, MD...
PSA Remains An Important Tool For Fighting Cancer Says Prostate Cancer Foundation
Responding to continued debate over PSA screening, and today's American Cancer Society statement, the Prostate Cancer Foundation (PCF) reiterated its position that PSA screening remains a valuable tool, in combination with other tools, for identifying potential prostate disease, including cancer...
Health Dialog Offers Decision Aids For Men Considering Prostate Cancer Screening
Health Dialog, a leading provider of healthcare analytics and decision support, today announced that its decision support tools for prostate cancer screening have been made available for the month of March as a public service offering...
Studies Presented At 2010 Genitourinary Cancers Symposium Advance Management, Treatment Of Prostate And Bladder Cancers
New studies on the treatment of genitourinary cancers were released today in advance of the third annual Genitourinary Cancers Symposium, being held March 5-7, 2010, at the San Francisco Marriott...
Complex New Guidelines From Multiple Organizations Confuses Men About Prostate Cancer Screening
Members of America's Prostate Cancer Organizations are concerned that the issuance this morning of yet another set of new guidelines on screening for prostate cancer is only adding to the confusion most men already feel about whether they should or shouldn't be tested for the most common form of cancer in American men...
Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival In Patients With Metastatic Castrate-Resistant Prostate Cancer
Dendreon Corporation (Nasdaq: DNDN) announced updated results from its pivotal Phase 3 IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment) study demonstrating that PROVENGE® (sipuleucel-T) extends overall survival in men with metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC)...
Cabazitaxel Increased Survival For Patients With Advanced Hormone-Refractory Prostate Cancer
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy...
Combination Therapy More Effective For Enlarged Prostate
Like any successful team effort, the best qualities of two drugs commonly prescribed for enlarged prostate yielded better results than either of the medicines alone, according to a new study from UT Southwestern Medical Center...
FDA Approves First Generic Tamsulosin To Treat Enlarged Prostate Gland
The U.S. Food and Drug Administration approved the first generic version of Flomax Capsules 0.4 mg (tamsulosin hydrochloride) to treat benign prostatic hyperplasia (BPH), a condition in which an enlarged prostate gland causes problems with urination...
Prostate Cancer Surgeons "Feel" With Their Eyes
Robotic surgical technology with its three-dimensional, high-definition view gives surgeons the sensation of touch, even as they operate from a remote console. A new study describes the phenomenon, called intersensory integration, and reports that surgical outcomes for prostate cancer surgery using minimally invasive robotic technology compare favorably with traditional invasive surgery...
Inclement East Coast Weather Delays ProUroScan(TM) FDA Review
ProUroCare Medical, Inc. (OCT Bulletin Board: PUMD, PUMDU, PUMDW), a provider of proprietary medical imaging products, indicates that the Food and Drug Administration has informed the industry that the processing of 510(k) applications, which includes the ProUroScanâ„¢ prostate imaging system, has been delayed because of the inclement weather in February that impacted the Washington, D.C...
Gleason Score And Laterality Concordance Between Prostate Biopsy And Prostatectomy Specimens
UroToday.com - Treatment decisions in prostate cancer are guided by Gleason grade and laterality (unilateral vs. bilateral) findings on prostate needle biopsy which samples a small proportion of the prostate. Surgical decisions with respect to nerve sparing and lymph node dissection are also influenced by prostate biopsy findings...
Effective Prostate Cancer Treatment Discovery
Monash University biomedical scientists have identified a new way to treat castrate resistant cells in prostate cancer sufferers - the most common cancer in Australian men. For more than 60 years the main way to treat men with prostate cancer has involved removing the hormones that fuel growth of the cancer cells...
The ASCO Cancer Foundation Awards $25,000 To Young Researchers For Important Contributions To Genitourinary Cancers Research
The ASCO Cancer Foundation will present Merit Awards to twenty-five leading oncology fellows from around the world at the 2010 Genitourinary (GU) Cancers Symposium, which takes place March 5-7 in San Francisco. These promising young fellows will be honored for their exceptional contributions to the research of genitourinary tract cancers...
Kinex Pharmaceuticals Initiates A Phase 2 Clinical Trial Of KX2-391 In Patients With Prostate Cancer
Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2-391 in patients with bone-metastatic, castrate-resistant prostate cancer (CRPC) who have not had prior chemotherapy...
Impact Of Positive Surgical Margins After Radical Prostatectomy Differs By Disease Risk Group
UroToday.com - There is great controversy regarding the prognostic value of positive surgical margins (PSM) after radical prostatectomy. In studies that have demonstrated an impact of PSM on the prognosis of prostate cancer, several clinical and pathological features of the disease were found to be associated with such an impact...
Prostate Cancer Detection Rate And Predictive Factors In Patients Undergoing Ultrasonography-guided Transperineal Saturation Biopsies Of The Prostate
UroToday.com - With regard to the prognostic factors predicting the diagnosis of prostate cancer, in our analysis, prostate volume was the unique clinical and pathological variable significantly associated with the incidence of prostate cancer in multivariate analysis [1]...
What It Might Take To Unravel The 'Lean Mean Machine' That Is Cancer
Scientists from Sydney's Garvan Institute of Medical Research have published a paper, online in Nature Cell Biology, describing gene expression in a prostate cancer cell: more sweeping, more targeted and more complex than we could ever have imagined, even five years ago...
Worlds Best Pharmacy
canadian meds shop
Why is your product so cheap? How do you ship orders? We accept : Visa, MasterCard, AmEx, Diners and JCB cards. |
